INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ)
$40.5 -0.8 (-1.937%)
Analysed INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) News Sources
5 Small Drug Stocks to Invest in Amid a Biotech Comeback
25-06-2026
yahoo.com
Reasons Why Investors Should Consider Betting on Indivior Stock
25-06-2026
yahoo.com
IBD 50 Stock Indivior Breaks Out Amid Big Fund Ownership Expansion, Strong Profit Prospects
25-06-2026
yahoo.com
Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker
26-06-2026
yahoo.com
Kymera Jumps 17% on Early Enrollment Completion in Skin Disease Study
26-06-2026
yahoo.com
IONS Out-Licenses ex-U.S. Rights for Rare Neurology Drug to Recordati
26-06-2026
yahoo.com
Bull of the Day: Neurocrine Biosciences (NBIX)
29-06-2026
yahoo.com
Indivior Pharmaceuticals Inc. (INDV) is on the Move, Here's Why the Trend Could be Sustainable
29-06-2026
yahoo.com
ACAD Stock Up as CHMP Backs Daybu for EU Approval in Rett Syndrome
29-06-2026
yahoo.com
Indivior’s Triple Russell 2000 Defensive Inclusion Could Be A Game Changer For Indivior Pharmaceuticals (INDV)
30-06-2026
yahoo.com
What is the current price of INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ)?
The current price of INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) is $40.5.
INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) absolute price change since previous trading day?
The absolute price change of INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) since the previous trading day is $-0.8.
INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) percentage price change since previous trading day?
The percentage price change of INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) since the previous trading day is -1.937%.
What is the most recent average sentiment score for INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ)?
The most recent average sentiment score for INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) is 73 out of 100.
What is the most recent average sentiment for INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ)?
The most recent sentiment for INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ) is .
SEC-8K** Filing Available For INDIVIOR PHARMACEUTICALS INC (INDV:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.